Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu 210006, China.
Department of Cardiology, Zhangjiagang First People's Hospital, Zhangjiagang, Jiangsu 215699, China.
Chin Med J (Engl). 2018 May 5;131(9):1023-1029. doi: 10.4103/0366-6999.230732.
The relationship between obstructive sleep apnea (OSA) and platelet reactivity in patients undergoing percutaneous coronary intervention (PCI) has not been defined. The present prospective, single-center study explored the relationship between platelet reactivity and OSA in patients with PCI.
A total of 242 patients were finally included in the study. OSA was screened overnight by polysomnography. Platelet reactivity was assessed with a sequential platelet counting method, and the platelet maximum aggregation ratio (MAR) and average aggregation ratio were calculated. All patients were assigned per apnea-hypopnea index (AHI) to non-OSA (n = 128) and OSA (n = 114) groups. The receiver operating characteristic curve analysis was used to evaluate the accuracy of AHI for high platelet reactivity (HPR) on aspirin and clopidogrel, and multivariable logistic regression was used to determine the independent predictors of HPR on aspirin and clopidogrel.
Median AHI was significantly higher in the OSA group than in the non-OSA group (34.5 events/h vs. 8.1 events/h, Z = -13.422, P < 0.001). Likewise, median arachidonic acid- and adenosine diphosphate-induced maximum aggregation rate (MAR) in the OSA group was significantly higher than those in the non-OSA group (21.1% vs. 17.7%, Z = -3.525, P < 0.001 and 45.8% vs. 32.2%, Z = -5.708, P < 0.001, respectively). Multivariable logistic regression showed that OSA was the only independent predictor for HPR on aspirin (odds ratio [OR]: 1.055, 95% confidence interval [CI]: 1.033-1.077, P < 0.001) and clopidogrel (OR: 1.036, 95% CI: 1.017-1.056, P < 0.001). The cutoff value of AHI for HPR on aspirin was 45.2 events/h (sensitivity 47.1% and specificity 91.3%), whereas cutoff value of AHI for HPR on clopidogrel was 21.3 events/h (sensitivity 68.3% and specificity 67.7%).
Platelet reactivity appeared to be higher in OSA patients with PCI despite having received a loading dose of aspirin and clopidogrel, and OSA might be an independent predictor of HPR on aspirin and clopidogrel.
阻塞性睡眠呼吸暂停(OSA)与经皮冠状动脉介入治疗(PCI)患者的血小板反应性之间的关系尚未明确。本前瞻性、单中心研究旨在探讨 PCI 患者中血小板反应性与 OSA 之间的关系。
共有 242 例患者最终纳入本研究。通过多导睡眠图(PSG)在夜间筛查 OSA。采用连续血小板计数法评估血小板反应性,并计算血小板最大聚集率(MAR)和平均聚集率。所有患者根据呼吸暂停低通气指数(AHI)分为非 OSA 组(n=128)和 OSA 组(n=114)。受试者工作特征曲线(ROC)分析用于评估 AHI 对阿司匹林和氯吡格雷高血小板反应性(HPR)的准确性,多变量逻辑回归用于确定阿司匹林和氯吡格雷 HPR 的独立预测因素。
OSA 组的中位 AHI 明显高于非 OSA 组(34.5 次/小时 vs. 8.1 次/小时,Z=-13.422,P<0.001)。同样,OSA 组花生四烯酸和二磷酸腺苷诱导的最大聚集率(MAR)的中位数也明显高于非 OSA 组(21.1% vs. 17.7%,Z=-3.525,P<0.001和 45.8% vs. 32.2%,Z=-5.708,P<0.001)。多变量逻辑回归显示,OSA 是阿司匹林(比值比[OR]:1.055,95%置信区间[CI]:1.033-1.077,P<0.001)和氯吡格雷(OR:1.036,95%CI:1.017-1.056,P<0.001)HPR 的唯一独立预测因素。阿司匹林 HPR 的 AHI 截断值为 45.2 次/小时(灵敏度 47.1%,特异性 91.3%),而氯吡格雷 HPR 的 AHI 截断值为 21.3 次/小时(灵敏度 68.3%,特异性 67.7%)。
尽管接受了阿司匹林和氯吡格雷的负荷剂量,但 PCI 合并 OSA 的患者血小板反应性似乎更高,OSA 可能是阿司匹林和氯吡格雷 HPR 的独立预测因素。